Marc N. Casper - Aug 6, 2025 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Role
Chairman & CEO, Director
Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Marc N. Casper
Stock symbol
TMO
Transactions as of
Aug 6, 2025
Transactions value $
-$3,581,963
Form type
4
Date filed
8/7/2025, 07:14 PM
Previous filing
May 22, 2025
Next filing
Aug 21, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CASPER MARC N Chairman & CEO, Director 168 THIRD AVENUE, WALTHAM /s/ Melodie T. Morin, Attorney-in-Fact for Marc N. Casper 2025-08-07 0001216055

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock Options Exercise $2.54M +10K +8.68% $253.99 125K Aug 6, 2025 Direct
transaction TMO Common Stock Sale -$245K -548 -0.44% $446.92 125K Aug 6, 2025 Direct F1, F2
transaction TMO Common Stock Sale -$563K -1.26K -1.01% $447.96 123K Aug 6, 2025 Direct F1, F3
transaction TMO Common Stock Sale -$515K -1.15K -0.93% $448.99 122K Aug 6, 2025 Direct F1, F4
transaction TMO Common Stock Sale -$781K -1.74K -1.42% $449.91 120K Aug 6, 2025 Direct F1, F5
transaction TMO Common Stock Sale -$400K -887 -0.74% $451.04 120K Aug 6, 2025 Direct F1, F6
transaction TMO Common Stock Sale -$285K -631 -0.53% $452.13 119K Aug 6, 2025 Direct F1, F7
transaction TMO Common Stock Sale -$367K -811 -0.68% $453.09 118K Aug 6, 2025 Direct F1, F8
transaction TMO Common Stock Sale -$257K -566 -0.48% $454.56 118K Aug 6, 2025 Direct F1, F9
transaction TMO Common Stock Sale -$617K -1.35K -1.15% $455.64 116K Aug 6, 2025 Direct F1, F10
transaction TMO Common Stock Sale -$241K -529 -0.46% $456.22 116K Aug 6, 2025 Direct F1, F11
transaction TMO Common Stock Sale -$115K -251 -0.22% $458.62 115K Aug 6, 2025 Direct F1, F12
transaction TMO Common Stock Sale -$7.35K -16 -0.01% $459.25 115K Aug 6, 2025 Direct F1
transaction TMO Common Stock Sale -$68.7K -149 -0.13% $461.31 115K Aug 6, 2025 Direct F1, F13
transaction TMO Common Stock Sale -$44.4K -96 -0.08% $462.32 115K Aug 6, 2025 Direct F1, F14
transaction TMO Common Stock Sale -$10.2K -22 -0.02% $464.68 115K Aug 6, 2025 Direct F1
transaction TMO Common Stock Options Exercise $2.03M +8K +6.95% $253.99 123K Aug 7, 2025 Direct
transaction TMO Common Stock Sale -$537K -1.19K -0.96% $452.68 122K Aug 7, 2025 Direct F1, F15
transaction TMO Common Stock Sale -$704K -1.55K -1.27% $453.40 120K Aug 7, 2025 Direct F1, F16
transaction TMO Common Stock Sale -$1.22M -2.68K -2.22% $454.57 118K Aug 7, 2025 Direct F1, F17
transaction TMO Common Stock Sale -$906K -1.99K -1.69% $455.56 116K Aug 7, 2025 Direct F1, F18
transaction TMO Common Stock Sale -$272K -596 -0.51% $456.41 115K Aug 7, 2025 Direct F1, F19
holding TMO Common Stock 11.3K Aug 6, 2025 By Alison Casper 2020 Irrevocable Trust F20
holding TMO Common Stock 14.6K Aug 6, 2025 By Floral Park Associates, Inc.
holding TMO Common Stock 5K Aug 6, 2025 By MNC 2020 Irrevocable Trust F21

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -10K -18.78% $0.00 43.3K Aug 6, 2025 Common Stock 10K $253.99 Direct F22
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -8K -18.5% $0.00 35.3K Aug 7, 2025 Common Stock 8K $253.99 Direct F22
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 28, 2025.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $446.39 to $447.245, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18) and (19) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $447.44 to $448.43, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $448.57 to $449.50, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $449.611 to $450.572, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $450.63 to $451.545, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $451.666 to $452.606, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $452.68 to $453.51, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $453.948 to $454.90, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $455.013 to $456.01, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $456.03 to $456.77, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $458.225 to $458.76, inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $460.67 to $461.56, inclusive.
F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $461.88 to $462.84, inclusive.
F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $452.06 to $453.004, inclusive.
F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $453.006 to $454.005, inclusive.
F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $454.026 to $455.015, inclusive.
F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $455.08 to $456.037, inclusive.
F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $456.11 to $456.876 inclusive.
F20 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
F21 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
F22 The option vested in four equal installments on February 26, 2020, 2021, 2022, and 2023.